𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I trial of perillyl alcohol administered four times daily continuously

✍ Scribed by Sherry Morgan-Meadows; Sarita Dubey; Michael Gould; Kendra Tutsch; Rebecca Marnocha; Rhoda Arzoomanin; Dona Alberti; Kimberly Binger; Chris Feierabend; Jennifer Volkman; Shawna Ellingen; Sandra Black; Marcia Pomplun; George Wilding; Howard Bailey

Publisher
Springer
Year
2003
Tongue
English
Weight
186 KB
Volume
52
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase I trial of the polyelectrolyte car
Phase I trial of the polyelectrolyte carbetimer administered i.v. once every four weeks
✍ Michael Fromm; Wolfgang E. Berdel; Hans D. Schick; Susanne Danhauser-Riedl; Ulri πŸ“‚ Article πŸ“… 1988 πŸ› Springer US 🌐 English βš– 461 KB

Carbetimer, a new synthetic low molecular weight polyelectrolyte with a novel structure displayed antitumor activiy in a number of animal tumor model systems and in vitro investigations. Based on these findings it was brought to a phase I clinical trial in patients with advanced malignant disease af

A Phase I trial of spirogermanium admini
A Phase I trial of spirogermanium administered on a continuous infusion schedule
✍ Paul V. Woolley; James D. Ahlgren; Patrick J. Byrne; Victor M. Priego; Philip S. πŸ“‚ Article πŸ“… 1984 πŸ› Springer US 🌐 English βš– 328 KB

We have evaluated the toxicity of the antitumor agent spirogermanium on a schedule of continuous intravenous administration for periods up to five days. The doses tested were between 100 mg/m 2/day and 500 mg/m 2/day. Peripheral vein phlebitis occurred at all dose levels and was not relieved by addi

A Phase I clinical trial of ixabepilone
A Phase I clinical trial of ixabepilone (BMS-247550), an epothilone B analog, administered intravenously on a daily schedule for 3 days
✍ Sen H. Zhuang; Manish Agrawal; Maureen Edgerly; Susan Bakke; Herb Kotz; Paul Tha πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 86 KB

## Abstract ## BACKGROUND The epothilones are a novel class of microtubule‐stabilizing agents. Ixabepilone (BMS‐247550; NSC 710428) is a semisynthetic analog of the natural product epothilone B. The authors conducted a Phase I study by administering ixabepilone to patients as a 1‐hour intravenous